ExxonMobil Gets Dual Analyst Boosts as Stock Falls 5% Toward 52-Week Lows
By TrendSpider Editor
Total actions: 2. Upgrades: 0. Downgrades: 0. The consensus rating remains constructive across both firms, with an average price target of $200. Neither action reflects a change in the directional rating, only an increase in price target conviction.
ExxonMobil Gets Dual Analyst Boosts as Stock Falls 5% Toward 52-Week Lows
ExxonMobil Holdings Corporation is drawing renewed analyst conviction today even as shares slide sharply, with UBS raising its price target to $213 and Morgan Stanley lifting its target to $187 on the same session. XOM is currently trading at $167.99, down 5.34% on the day, sitting well below the consensus average price target of $200. That current price places the stock in the lower half of its 52-week range of $112.51 to $188.50, underscoring the tension between analyst optimism and near-term selling pressure.Key Drivers of the XOM Stock Move
- Main Catalyst: Two separate analyst actions hit the tape today. UBS analyst Manav Gupta confirmed a "buy" rating and raised his price target from $199 to $213. Morgan Stanley analyst Devin McDermott also confirmed a "buy" and nudged his target higher from $185 to $187. Neither firm issued a downgrade, making today's analyst tape uniformly constructive.
- Bull Case: Both price target increases point to meaningful upside from current levels. The UBS target of $213 represents roughly 26.8% implied upside from the current price of $167.99, while Morgan Stanley's $187 target still implies approximately 11.3% upside. The consensus average price target of $200 also sits comfortably above today's trading price, suggesting the broader analyst community sees the selloff as disconnected from fundamental value.
- Bear Case: Despite unanimous analyst support, XOM shares are falling 5.34% today, one of the sharper single-session declines the stock has seen within its current 52-week range. Morgan Stanley's price target of $187 is actually below the 52-week high of $188.50, suggesting at least one major firm sees limited room for the stock to reclaim prior peaks. The gap between UBS and Morgan Stanley targets of $26 also signals divergent views on how aggressively XOM can recover.
XOM Analyst Ratings and Price Targets
- UBS (Manav Gupta): Confirmed "buy" rating. Price target raised to $213 from a prior target of $199.
- Morgan Stanley (Devin McDermott): Confirmed "buy" rating. Price target raised to $187 from a prior target of $185.
Total actions: 2. Upgrades: 0. Downgrades: 0. The consensus rating remains constructive across both firms, with an average price target of $200. Neither action reflects a change in the directional rating, only an increase in price target conviction.
XOM Seasonality
Historically, energy stocks including large-cap integrated names like ExxonMobil have shown mixed performance in early November as markets begin pricing in winter demand expectations and year-end portfolio rebalancing. A sharp single-day drop of this magnitude in early November can sometimes mark a tactical entry point if seasonal demand trends for energy align with analyst expectations heading into the colder months.XOM Relative Performance
XOM's 5.34% decline today is a notable underperformer relative to the broader market and likely relative to energy sector peers, given the magnitude of the move. With the stock at $167.99 against a 52-week high of $188.50, ExxonMobil has pulled back approximately 10.9% from its annual peak. At the same time, the stock remains well above its 52-week low of $112.51, meaning the longer-term trend has not been violated even as short-term pressure intensifies.More on XOM
- ExxonMobil Hovers Just Below 52-Week High at $187.14 as Momentum Stalls
- ExxonMobil Crushes Q3 2026 Estimates With 125% Earnings Growth as Stock Breaks to New 52-Week High
- ExxonMobil Hovers Near 52-Week High as Shares Push Toward $184.88 Ceiling
- ExxonMobil Surges 1.68% to $182.91, Pressing Against Its 52-Week High
- ExxonMobil Hovers Just Below 52-Week High as Shares Consolidate Near $184.58
Latest Market News
- Apple Stock Surges 6.44% as 10 Analysts Reprice AAPL With Targets Ranging From $250 to $400
- Microsoft Stock Breaks Above 52-Week High With a 6.60% Single-Session Surge
- Amazon Stock Surges 7.52% as Freedom Broker Raises Price Target to $330
- Home Depot Surges 5.48% as Shares Climb Back Toward 52-Week Highs
- Eli Lilly Climbs to $1,421.75, Pressing Near Its 52-Week Peak of $1,449.68
- Abbott Laboratories Jumps 5.82% Wednesday, Reclaiming Key Price Territory in Strong Session